Søren Echwald Morgenthaler

Søren Echwald Morgenthaler provides expertise in patent strategy, freedom to operate analysis, and business strategy. He has listed one life sciences company and is or has been engaged with Anapa Biotech, Exiqon, and Novo Nordisk.